在帕金森病中重编程慢性下丘脑刺激的临床益处
Jumpei Sugiyama1, Yuwa Oka2,3, Shohei Imanaka2
1Department of Neurosurgery, Medical Research Institute Kitano Hospital, Osaka, Japan.
Movement disorders clinical practice
|August 29, 2025
概括
对帕金森病进行深度大脑刺激 (DBS) 的系统重新编程显著改善了运动功能. 这种方法提高了底核 (STN) DBS 患者的长期结果.
科学领域:
- 神经学
- 神经外科
- 生物医学工程
背景情况:
- 深度大脑刺激 (DBS) 是帕金森病 (PD) 的关键疗法.
- 尽管有潜在的好处,但现有DBS设置的重新编程往往未得到充分利用.
- 慢性脑下细胞核 (STN) DBS 需要定期优化以保持有效性.
研究的目的:
- 在长期STN DBS患者中评估系统重编程的临床影响.
- 在重新编程后评估运动功能和药物需求的变化.
- 探索有效的STN DBS重编程的成像相关性.
主要方法:
- 由于症状复发,10名长期STN DBS患者进行了系统的重编程.
- 运动障碍学会统一帕金森病评分表 (MDS- UPDRS) 第三部分分数 (停用药物/ DBS ON) 进行了比较.
- 在重新编程前和之后分析了莱沃多巴每日相当剂量 (LEDD) 和成像数据.
主要成果:
- 重编程导致MDS- UPDRS第三部分分数显著提高24% (P=0. 02).
- 在重新编程后没有观察到LEDD的显著变化.
- 图像显示重新编程通常涉及背侧或STN上部区域,调整刺激参数.
结论:
- 系统重编程是一种有效的策略,用于提高长期的运动结果STN DBS帕金森病.
- 图像可以帮助理解和指导STN DBS的最佳重编程策略.
- 通过重新编程优化DBS参数提供了一种有价值的非药物治疗方法来控制PD症状.
更多相关视频
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.9K
10:52Microelectrode Guided Implantation of Electrodes into the Subthalamic Nucleus of Rats for Long-term Deep Brain Stimulation
Published on: October 2, 2015
19.9K
相关概念视频
01:24Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
01:15Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702